article thumbnail

OIG Reaffirms Its Concern About “Carving Out” Federal Health Care Program Business

Health Care Law Brief

Consistent with and as has been elaborated in its 2014 Special Fraud Alert , OIG reasoned that such arrangements may implicate and potentially violate the AKS by “disguising” remuneration for FHCP business through the payment of amounts purportedly related to non-FHCP ( e.g. , commercial) business. .

article thumbnail

Managing Healthcare Compliance in Florida

MedTrainer

Florida Healthcare Compliance Resources Let’s start with the important state government agencies you’ll need to work with: The Florida Department of Health (DOH) plays a crucial role in promoting and safeguarding the wellbeing of Floridians. While many states have rules that prohibit the storage of Medicaid data outside the U.S.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Empathy-First Approach: Choosing Technology that Benefits All Healthcare Stakeholders

Healthcare IT Today

Payers have to manage complex payment systems, track performance, and ensure regulatory compliance. In 2014, he received the Louis J. The current healthcare system is rife with administrative inefficiencies and redundancies, which can lead to delayed or denied payments for payers.

article thumbnail

FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors

Hall Render

Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014.

article thumbnail

The Supreme Court Denies Petition Challenging CMS’s Overpayment Rule

Health Care Law Brief

29844, 29921 (May 23, 2014). The District Court judge specifically noted that, “[t]he effect of the 2014 [O]verpayment [R]ule, without some kind of adjustment, is that [MA plans] will be paid less to provide the same health care coverage to their beneficiaries than [FFS Medicare] pays for comparable patients.” Azar , Civil Case No.

article thumbnail

Medical Technology – Recent Decisions at the Federal Circuit and the Patent Trial and Appeal Board

Healthcare Law Blog

One basis for early action has been legal consequences arising from preparations for marketing and sale of a medical device invention, including regulatory compliance. 208, 216 (2014). SUBJECT MATTER ELIGIBILITY AT THE BOARD Occasionally, the PTAB will reverse an examiner’s final rejection. CLS Bank Int’l , 573 U.S.